In the present study, we investigated the association of CYP2C9*2 and *3 alleles and their genotypes with SIH in T2DM patients who were being treated with sulphonylurea drugs such as glimepiride or gliclazide. This evidence concerns the gene CYP2C9 and type 2 diabetes mellitus.